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lnterleukin-6 (IL6) exerts its action via a cell surface receptor composed or an 80 kDa IL6-binding protein (gp80) and a 130 kDa polypeptlde 
involved in signal transduetion (gp130). We studied the role of gpB0 in binding, internalization a d down-regulation f the hepatic IL6-receptor 
(IL6R) by its ligand in human hepatoma cells (HepG2). Comparison of tranffected HepG2 cells overexpr~sinB gpB0 with parental cell~ indicate 
that gpS0 is responsible for low affinity binding (Ka = 500 pM) of IL6. Furthermore, gpS0 is rate-limiting in internalization a d degradation of
IL6. Internalization resulted in a rapid down-regulation (t~. ~ 15-30 rain) of I L6-binding sites at the cell surface. More than B0% of the internalized 
[~2~l]rhlL6 was degraded. The reappearance of IL6-binding sites at the cell surface required >8 h and was sensitive to cyeloheximide0 su$Sestin B 
that gpB0 is not recycled after internalization. The down-regulation f the hepatic IL6R by its tigand might play an important role as a protection 
a~inst overstimulation. 
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1. INTRODUCTION 
Interleukin-6 (IL6) is a multifunetional cytokine syn- 
thesized by many different cells after appropriate stimu- 
lation. IL6 acts on a wide spectrum of target cells. It has 
been reported to he involved in: (i) the induction of 
immunoglobulin production in activated B-cells; (ii) the 
induction of proliferation of hybridoma/plasmacytoma/ 
myeloma cells; (iii) the induction of interleukin-2 in T- 
cells, in cell growth and differentiation of T-cells to 
cytotoxic T-cells; (iv) the stimulation of multipotent col- 
ony formation in hematopoietic stem cells; and (v) the 
regulation of acute-phase, proteins in liver (see reviews 
[1-51). 
IL6 exerts its action via cell-surface receptors com- 
posed of two subunits: an 80 kDa IL6-binding protein 
(gp 80) and a 130 kDa glycoprotein (gp 130) involved 
in signal transduction [6]. The cDNAs for both subunits 
have recently been cloned from natural killer cells and 
human placenta, respectively [7,8I. In liver, in hepato- 
cytes in primary culture and in hepatoma cells, IL6 has 
been shown to be a major regulator of'acute-phase pro- 
rein synthesis [9-11]. 
As an approach to understand the interaction of IL6 
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with its target cells, we studied the binding, internaliza- 
tion and degradation of IL6 in HepG2 cells and in 
HepG2 cells overexpressing the 80 kDa IL6-receptor 
binding subunit. We demonstrate that IL6 down-regu- 
lates its surface receptor via endocytosis. The extent of 
internalization is determined by the number of 80 kDa 
1L6-receptor subunits. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Carrier-free Nat'~l (559 MBq/g) was obtained from Amersham In- 
ternational (Amersham, UK), iodobeads were from Pierce Chemical 
Co. (Rockford, IL, USA). Dulbeoco's modified Eagles medium was 
from Gibco (Eggenstein, German>'), fetal calf scram from Seromed 
(Berlin, German),). Haman recombinant interleukin-6 (5× 10 ~ B-cell 
stimulator), factor-2 units/~tg protein) was kindly provided by Drs. T. 
Hirano and T. Kishlmoto (Osaka University, Japan). 
2.2. Ci, II cultures 
HepG2 cells were cultured in Dulbeceo's modified Eagle's medium 
containing 10% fetal calf ~erum, 61 mg~'l penicillin and 100 toNI strep- 
tonayein. HepG2-80kD cells were ~u'.blished after stable transfeetion 
of HepG2 ceils with the coding region for the IL6R 80 kDa subtmit 
as previously described [12]. To induce the expre~ion of the IL6R 80 
kDa subunit, HepG2.80kD ceils were incubated with 100/.tM ZnCl~ 
for at least 8 h. 
2.3. Inclination of rhlL6 
RhlL6 was iodinated according to the procedure of Markwell [131 
with modifications a  previously described [14]. A specific radioactiv- 
ity of 800 kBq//.tg was obtained. The biological activity of the iodi- 
nated IL6 was essentially unchanged [14]. 
Publtshed by Elsevier Science Publishers B.V. 219 
Volume 306, number 2,3 FEBS LETTERS July 1992 
2.4. Bhuting studies 
Cells were grown to conflaency using 24-muhi-well plates. After 
conflueney was reached (5 x 105 cells/well), cells were washed twice 
with ice-cold binding medium (Dulbeceo's modified Eagle's medium 
without bicarbonate containing 0.2% (w/v) bovine serum albumin and 
20 mM HEPE5 buffer, pH 7.0). Binding was initiated by the addition 
of [~"51]rhlL6 at different eon~ntrations (1-2,048 pM) to duplicate 
wells. After incubation at 4"C for 2.5 h, medium wa~ removed and 
cells were washed three times with phosphate-buffered saline contain. 
in~ 1 mM MBCI:, 0.1 mM CaCl2 and 0.2% bovine serum albumin. 
Cells were subsequently solubilized in 1 ml of I M NaOH and radio- 
aetivitl¢ was measured. Non-specific binding was determined by incu- 
bating the ceils with [~25I]rhlL6 and a 100-fold excess of non.labelled 
li~and. 
2.5, lnterttali=atlon stud/es 
In a total volume of I ml of binding medium, 2.5 x 10" cells per 35 
mm dish were preloaded with 1 nM of [~'-Sl]rhlL6 at 4°C for 2 h. 
Internalization was initiated by warming up the cells to 37°C. At 
different imes of incubation, ¢¢11s w~L¢ washed t~vi~e with binding 
medium. Surface.bound [t-'~IlrhlL6 was determined alter subjecting 
the cells to 0.5 M NaCI/HCI, pH 1, for 3 rain followed by an additional 
wash with phosphate-buffered saline contai,~ing 0.2% bovine serum 
albumin. 
Internalized [t:~l]rhlL6 was determined after l:¢sis of the cells in 1 
ml of I M NaOH. In some experiments the medium after exposure of 
the cells to ['"~l]rhlL6 was analyted for triehloroacede acid-soluble 
and -pn.-elpltable radioactivity as described [15]. All measurements 
were performed in duplicate. 
3. RESULTS 
Liver and hepatoma cells are characterized by a low 
number of binding sites for IL6 [16,17]. Fig. 1 (upper 
panel) shows results of a binding study of [12al]rhlL6 to 
human hepatoma cells (HepG2). From the Scatchard 
plot one type of high affinity binding sites (Xd ~ 60 pM) 
and about 2000 receptors per cell can be deduced. These 
data are in agreement with the findings of Sonne et al. 
[17]. In contrast, Baumann and coworkers [18] de- 
scribed two classes of IL6-binding sites on these cells: 
5000 of low affinity (Kd., = 500 pM) and about 450 of 
high affinity (K,~ = 15 pM). 
Since we were interested to study the role played by 
the 80 kD~IL6-receptor subunit (gpg0) in binding and 
internalization, we stably transfected HepG2 ceils with 
the respective eDNA under the transcriptional control 
of the mouse metallothionein I promoter (HepG2- 
80kD) [12]. These cells would allow t!s to e×perimentally 
manipulate the number of binding sites at the cell sur- 
face. Upon incubation of HepG2-80kD with 100/zM 
ZnCh. the gpg0 mRNA was maximally induced after 4 
h whereas maximal IL6-binding to the cell surface was 
observed after 6-8 h (data not shown). 
Non-stimulated HepG2-80kD cells displayed essen- 
tially the same type of high-affinity binding sites as 
I-IepG2 cells (Fig. 1, middle panel). However, after stim- 
ulation with ZnClz, they exhibited additional low-affin- 
ity binding sites (K,,~ ~ 500 pM, 12,000 receptors per 
cell), whereas the number of high affinity sites changed 
only slightly (Fig. 1, lower panel). We conclude from 
this that gpg0 binds its ligand with low affinity, whereas 
70 
60  
50' 
" 40' @ 
20' 
10' 
70' 
60' 
u, 40' @ 
20 
I0 
HepG2 
Hep G 2 - 80 kD 
-ZnCI  2 
70 " 4 _ "  " - " . . . . . . .  
oo~,~ Hep G2 -80kD 
5o~ _ '~ + ZnCi 2 
10 
0 1 2 3 4 5 6 7 ~ 9 10 11 
~zsI-IL-6 bound ( .  10 "a molecules/coil) 
Fig, 1. Concentration dependence of binding of [~"'~i]rblL6 to I-[epG2 
cells and HepG2 cells overexpressing the 80 kDa 1L6R ~ubunit, Nor- 
mal HepG2 cells (HepG2) and transfeeted HepG2 cells (l-lepG2. 
80kD) and transfected HepG2 cells treated with 0.t mM ZnCI_, 
(HepG2- 80KD + ZnCI2) were incubated with [~"~l]rhlL6 at different 
concentrations at 4°C for 2.5 h. Specific binding was measured as 
detailed in Material~ and Methods and the data were transformed 
using a Scatchard analysis. Data represent the results of at least 3 
different experiments. 
the high affinity binding is most likely due to complex 
formation of IL6, gp80 and the signal transducing 
gpl30. Our finding complements he experiment per- 
formed by Hibi et al. [8] where the authors ha~e shown 
that after transfection ofhuman gp130-eDNA into Jur- 
kat cells the number of high affinity binding ,ites had 
increased, 
In order to learn more about the fate of IL6 and its 
receptor after their interaction, we performed internali- 
zation studies with HepG2 cells. Cells were preloaded 
with [~2SI]rhlL6 at 4°C for 2 h. After a temperature shift 
to 37°C surlhce-bound and internalized ['2SI]rhlL6 was 
determined atdifferent imes. [~'-~I]rhlL6 was present in 
the medium during the whole duration of the experi- 
ment. It can be seen in Fig. 2 (upper panel) that 
[~25I]rhlL6 was rapidly internalized (triangles). Con- 
eomitantly surface-binding sites for IL6 were lost (cir- 
cles). We conclude from this observation that IL6 
down-reguhttes it  surface receptor. 
220 
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Studies with HepG2 cells overexpressing gp80 re- 
vealed an increase in internalization of [mI]rhlL6 pro- 
portional to the increased cell surface re~ptor numbers 
(Fig. 2, lower panel). Since the additional binding sites 
in HepG2-80 kD cells are mainly of low affinity type, 
we conclude that 1L6-internalization can occur via gpS0 
alone. 
We investigated whether the [~'~5I]rhlL6 taken up by 
these cells is degraded or recycled and secreted. We 
allowed the cells to internalize [t-'Sl]rhlL6 for 1 h at 
37°C, medium containing the radioactivity labelled li. 
gand was replaced by normal binding medium and the 
cells were further incubated. Trichloroacetic acid-we- 
cipitable and trichloroacetic acid-soluble radioactivity 
in the culture medium was determined atdifferent times. 
More than 80% of the [~"Sl]rhlL6 internalized within 1 
h was degraded after 4 h. 
In order to find out, whether the receptor is degraded 
along with its ligand or recycles to the plasma mem- 
brane, we incubated HepG2 cells with saturating 
amounts of unlabelled IL6 at 37°C for 2 h to down- 
regulate the IL6-receptor. After removal of the ligand, 
cells were further incubated up to 24 h and the number 
of binding sites was determined with [~2~l]rhlL6. It took 
>8 h to completely restore the IL6 binding capacity of 
the HepG2 cells (Fig. 3, circles). This very .~low reap- 
pearance of IL6 binding sites is inhibited by cyclo- 
heximide (triangles) suggesting IL6-receptor de nero 
synthesis. 
4. DISCUSSION 
For several growth factors like insulin, epidermal 
growth factor or platelet-derived growth factor, it has 
been shown that, after binding, the respective receptors 
are internalized and down-regulated [19-23]. In the 
present study we have investigated the fate of the he- 
patic IL6-receptor and its ligand after their interaction. 
We show that in HepG2 cells and HepG2-80kD cells 
IL6 is rapidly internalized and that it concomitantly 
down-regulates it cell surface receptors with a tt/2 of 
15-30 rain. Without IL6 gpS0 in HepG2-80kD cells has 
a half-life of about 7 h (data not shown). The internal- 
ized ligand is degraded. There are two possible path- 
ways for the internalized IL6-receptor. It can be de- 
graded together with its ligand in the lysosomal com- 
partment or it can be separated from its ligand and 
recycled to the plasma membrane. Separation of the 
receptor and the ligand in the endosomal compartment 
usually occurs at a pH around 5..e, ince it is not possible 
to dissociate [~-~I]rhlL6 from its surface-bound receptor 
at pH ~, 5 (unpublished data), it is unlikely that a sepa- 
ration of 1L6 from its receptor occurs in the endosome. 
It is therefore more likely that the receptor is degraded 
together with its ligand. Our observation that the reap- 
pearance of IL6-binding sites after down.regulation re- 
quires >8 h and is cycloheximide s nsitive, is in agree- 
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Fig. 2. Internalization f[tZSl]rhlL6 by HepO2 and HepG2-80kDoglls. 
2.5 × 106 cells were preineubatgd with I nM [a'-~i]rhlL6 at 4"C for 2 
h. Temperature was shifted to 370C and surface-tmund ['nl]rhlL6 
(circles) and internalized [t'~l]rhlk6 (triangles) was determined as de- 
scribed in Materials and Methods. The data represent the results of 
at least 2 separate xperiments. Upper panel=normal HgpG2 cells; 
lower panel=HepG2-80kD cells, 
ment with tiffs notion. Attempts to directly demonstrate 
the degradation of the 80 kDa IL6-receptor subunit 
failed, because we were unable to metabolically abel 
this protein in parental hepatoma ceils and also in cells 
overenpressing gpS0. 
In previous experiments with human hepatoeytes in 
primary culture we could not detect internalization and 
degradation of [~al]rhlL6 [24], possibly due to the in- 
sensitive methods used at this time. In a recent publica. 
ties the internalization and degradation of IL6 was 
shown in primary rat hepatocytes with kinetics compa- 
rable with ours. However, these authors did not study 
the down-regulation f the IL6R by its ligand [25]. 
As mentioned before, the IL6R consists of the 80 kDa 
binding protein and in addition a 130 kDa glycoprotein 
involved in signal transduction. Therefore, the question 
arises whether gpl30 is also internalized. We are cur- 
rently enploring this question. 
Three general functions for receptor-mediated en o- 
cytosis are known: (i) uptake of nutritional molecules 
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Fis, 3. Reappearance of IL6.bindin$ sites at the cell surface after 
down- regulation of the IL6R in HepG2 cells, For the down-regulation 
of the IL6R, 2,5 × 106 HepG2 cells were incubated with 1 nM of 
unlabelled rhlL6 at 37°C for 2 h. After removal of the ligand by 3 
subsequent washes with binding medium, cells wer~ further incubated 
at 37"C without (circles) or with 10/~g/ml ofcyeloheximide (triangles). 
At the times indicated in the figure, the number of binding sites per 
cell was determined as described in the legend to Fig, 1, The square 
represents he number of total binding sites before the start of the 
experiment. The data presented are the mean of 2 separate xperi- 
ments performed in duplicate, 
such as lo'w density l ipoprotein and transferrin; (ii) re- 
mova l  o f  injur ious agents f rom the circulat ion such as 
galactose- or mannose- termina l  g ycoproteins;  and (iii) 
internal izat ion of  signaling molecules such as 
hormones ,  growth  factors and cytokines [26]. The re- 
ceptors  o f  the first two classes are usual ly recycled after  
endocytosis ,  whereas the signaling receptors in most  
cases do not  get recycled. They  are often degraded to-  
gether with their l igands. We show here for the first t ime 
that  this is also the case for the IL6R,  The subsequent  
desensit izat ion [26a] may be a protect ion of  the cell 
against  overst imulat ion.  It is not known whether  signal 
t ransduct ion  and internal ization are l inked processes 
for cytok ine receptors.  For  the interleukin-1 receptor  
and interleukin-2 receptor it was recently shown that  
receptor  mutants  incapable o f  signal transduct ion were 
still internal ized [27,28]. On the other  hand, it has been 
reported for  the interleukin-2 receptor that impa i rment  
o f  internal izat ion also inhibited signaling [29], For  the 
I L6R this will be the subject o f  future investigations. 
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